TY - JOUR
T1 - Management of Brain Arteriovenous Malformations
T2 - A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association
AU - Derdeyn, Colin P.
AU - Zipfel, Gregory J.
AU - Albuquerque, Felipe C.
AU - Cooke, Daniel L.
AU - Feldmann, Edward
AU - Sheehan, Jason P.
AU - Torner, James C.
N1 - Publisher Copyright:
© 2017 American Heart Association, Inc.
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Purpose-The aim of this statement is to review the current data and to make suggestions for the diagnosis and management of both ruptured and unruptured brain arteriovenous malformations. Methods-The writing group met in person and by teleconference to establish search terms and to discuss narrative text and suggestions. Authors performed their own literature searches of PubMed, Medline, or Embase, specific to their allocated section, through the end of January 2015. Prerelease review of the draft statement was performed by expert peer reviewers and by the members of the Stroke Council Scientific Oversight Committee and Stroke Council Leadership Committee. Results-The focus of the scientific statement was subdivided into epidemiology; diagnosis; natural history; treatment, including the roles of surgery, stereotactic radiosurgery, and embolization; and management of ruptured and unruptured brain arteriovenous malformations. Areas requiring more evidence were identified. Conclusions-Brain arteriovenous malformations are a relatively uncommon but important cause of hemorrhagic stroke, especially in young adults. This statement describes the current knowledge of the natural history and treatment of patients with ruptured and unruptured brain arteriovenous malformations, suggestions for management, and implications for future research.
AB - Purpose-The aim of this statement is to review the current data and to make suggestions for the diagnosis and management of both ruptured and unruptured brain arteriovenous malformations. Methods-The writing group met in person and by teleconference to establish search terms and to discuss narrative text and suggestions. Authors performed their own literature searches of PubMed, Medline, or Embase, specific to their allocated section, through the end of January 2015. Prerelease review of the draft statement was performed by expert peer reviewers and by the members of the Stroke Council Scientific Oversight Committee and Stroke Council Leadership Committee. Results-The focus of the scientific statement was subdivided into epidemiology; diagnosis; natural history; treatment, including the roles of surgery, stereotactic radiosurgery, and embolization; and management of ruptured and unruptured brain arteriovenous malformations. Areas requiring more evidence were identified. Conclusions-Brain arteriovenous malformations are a relatively uncommon but important cause of hemorrhagic stroke, especially in young adults. This statement describes the current knowledge of the natural history and treatment of patients with ruptured and unruptured brain arteriovenous malformations, suggestions for management, and implications for future research.
KW - AHA Scientific Statements
KW - arteriovenous malformations
KW - cerebral hemorrhage
KW - diagnosis
KW - embolization, therapeutic
KW - intracranial hemorrhages
KW - neurosurgery
KW - radiosurgery
UR - http://www.scopus.com/inward/record.url?scp=85021261552&partnerID=8YFLogxK
U2 - 10.1161/STR.0000000000000134
DO - 10.1161/STR.0000000000000134
M3 - Review article
C2 - 28642352
AN - SCOPUS:85021261552
SN - 0039-2499
VL - 48
SP - e200-e224
JO - Stroke
JF - Stroke
IS - 8
ER -